Wednesday, July 8, 2026

Drug profile · INN

technetium tc-99m apcitide

technetium tc-99m apcitide (ACUTECT) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — technetium tc-99m apcitide
US status
approved
Class
Route
INJECTION
Patents
0
Programs
1
Data quality
0.84

Quick answer

technetium tc-99m apcitide (ACUTECT) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN technetium tc-99m apcitide
Brand ACUTECT
Mechanism Diagnostic agent
Route INJECTION
Formulation INJECTABLE

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. PCI Phase 2 · Rhythm Pharmaceuticals Netherlands · Myocardial Infarction

Frequently asked questions

What is technetium tc-99m apcitide?

technetium tc-99m apcitide (ACUTECT) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for technetium tc-99m apcitide?

ACUTECT is a marketed brand name for technetium tc-99m apcitide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of technetium tc-99m apcitide?

technetium tc-99m apcitide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.